Tyra Biosciences, Inc.
TYRA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001863127
In the last 90 days, Tyra Biosciences, Inc. insiders filed 1 open-market purchase and 0 sales; 168 institutions reported holding it in 13F filings for Q2 2026, worth $2.22B in total; no superinvestor holds it.
13F holders, Q2 2022
Institutional positions in Tyra Biosciences, Inc. as of Jun 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 48
- +3 vs. Q1 2022
- Shares held
- 35.7M
- −387.7K (−1.1%) vs. Q1 2022
- Total value
- $255.6M
- −$131.0M (−33.9%) vs. Q1 2022
- New holders
- 6
- 18 more added
- Sold out
- 3
- 16 more reduced
1 institution that held it in Q1 2022 haven't filed for Q2 2022 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q1 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TYRA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 168 | $2.22B |
| Q1 2026 | 164 | $2.52B |
| Q4 2025 | 133 | $1.49B |
| Q3 2025 | 116 | $778.4M |
| Q2 2025 | 121 | $541.5M |
| Q1 2025 | 117 | $499.5M |
| Q4 2024 | 113 | $675.8M |
| Q3 2024 | 95 | $1.11B |
| Q2 2024 | 79 | $748.6M |
| Q1 2024 | 77 | $768.4M |
| Q4 2023 | 62 | $495.2M |
| Q3 2023 | 59 | $502.1M |
| Q2 2023 | 59 | $616.7M |
| Q1 2023 | 51 | $573.0M |
| Q4 2022 | 46 | $267.8M |
| Q3 2022 | 49 | $313.8M |
| Q2 2022 | 48 | $255.6M |
| Q1 2022 | 46 | $386.6M |
| Q4 2021 | 45 | $494.2M |
| Q3 2021 | 26 | $456.8M |
| Q2 2021 | 0 | $0 |
| Q1 2021 | 0 | $0 |
Institutions, Q2 2022
Shares, value and share of portfolio for each institution holding Tyra Biosciences, Inc.; share changes are against Q1 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| The PNC Financial Services Group, Inc. | 58 | $0 | 0.00% | +58 | New |
| Credit Suisse AG | 34 | $0 | 0.00% | +34 | New |
| Advisor Group Holdings, Inc. | 1 | $0 | 0.00% | +1 | New |
| Wells Fargo & Company | 153 | $1.00K | 0.00% | −2,409−94.0% | Reduced |
| Royal Bank of Canada | 74 | $1.00K | 0.00% | −651−89.8% | Reduced |
| Barclays PLC | 658 | $5.00K | 0.00% | −1,257−65.6% | Reduced |
| Ameritas Investment Partners, Inc. | 940 | $6.00K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 961 | $7.00K | 0.00% | −165−14.7% | Reduced |
| Citigroup Inc | 934 | $7.00K | 0.00% | +475+103.5% | Added |
| Amalgamated Bank | 1,621 | $12.0K | 0.00% | −150−8.5% | Reduced |
| Tower Research Capital LLC (TRC) | 2,937 | $21.0K | 0.00% | +1,694+136.3% | Added |
| California State Teachers Retirement System | 5,612 | $40.0K | 0.00% | +548+10.8% | Added |
| Deutsche Bank AG | 5,797 | $41.0K | 0.00% | −816−12.3% | Reduced |
| American International Group, Inc. | 6,142 | $44.0K | 0.00% | +286+4.9% | Added |
| New York State Common Retirement Fund | 10,488 | $75.0K | 0.00% | −29−0.3% | Reduced |
| Bailard, Inc. | 12,910 | $92.0K | 0.00% | +12,910 | New |
| Morgan Stanley | 13,436 | $96.0K | 0.00% | +11,865+755.3% | Added |
| Susquehanna International Group, LLP | 16,663 | $119.0K | 0.00% | +16,663 | New |
| Rhumbline Advisers | 17,285 | $124.0K | 0.00% | +5,559+47.4% | Added |
| Nuveen Asset Management, LLC | 18,756 | $134.0K | 0.00% | +356+1.9% | Added |
| Bank of America Corp | 19,719 | $141.0K | 0.00% | −44,407−69.2% | Reduced |
| LPL Financial LLC | 20,500 | $147.0K | 0.00% | +20,500 | New |
| Bank of New York Mellon Corp | 31,911 | $228.0K | 0.00% | +1,291+4.2% | Added |
| Wellington Management Group LLP | 54,864 | $392.0K | 0.00% | −196,358−78.2% | Reduced |
| D. E. Shaw & Co., Inc. | 56,054 | $401.0K | 0.00% | −27,384−32.8% | Reduced |
| Citadel Advisors LLC | 74,845 | $535.0K | 0.00% | −3,464−4.4% | Reduced |
| Charles Schwab Investment Management Inc | 81,301 | $582.0K | 0.00% | +845+1.1% | Added |
| Northern Trust Corp | 103,134 | $738.0K | 0.00% | +3,030+3.0% | Added |
| Sio Capital Management, LLC | 152,159 | $1.09M | 0.43% | +41,126+37.0% | Added |
| Logos Global Management LP | 166,526 | $1.19M | 0.22% | −86,200−34.1% | Reduced |
| State Street Corp | 214,025 | $1.53M | 0.00% | +10,345+5.1% | Added |
| JPMorgan Chase & Co | 224,492 | $1.60M | 0.00% | −3,990−1.7% | Reduced |
| Geode Capital Management, LLC | 225,411 | $1.61M | 0.00% | +14,862+7.1% | Added |
| Woodline Partners LP | 289,172 | $2.07M | 0.03% | +23,011+8.6% | Added |
| Perceptive Advisors LLC | 494,403 | $3.54M | 0.11% | 00.0% | Unchanged |
| Vanguard Group Inc | 591,109 | $4.23M | 0.00% | +75,472+14.6% | Added |
| BlackRock Inc. | 630,855 | $4.51M | 0.00% | +47,619+8.2% | Added |
| Janus Henderson Group PLC | 712,299 | $5.09M | 0.00% | −196,893−21.7% | Reduced |
| Cormorant Asset Management, LP | 743,988 | $5.32M | 0.41% | −13,444−1.8% | Reduced |
| TCG Crossover Management, LLC | 896,418 | $6.41M | 2.72% | 00.0% | Unchanged |
| Frazier Life Sciences Management, L.P. | 1,375,065 | $9.83M | 0.93% | +47,400+3.6% | Added |
| Fairmount Funds Management LLC | 1,416,998 | $10.1M | 2.32% | +132,008+10.3% | Added |
| BVF Inc | 2,472,327 | $17.7M | 0.85% | 00.0% | Unchanged |
| Nextech Invest AG | 2,518,582 | $18.0M | 6.07% | 00.0% | Unchanged |
| FMR LLC | 3,968,090 | $28.4M | 0.00% | −121,995−3.0% | Reduced |
| Canaan Partners XI LLC | 4,409,991 | $31.5M | 11.23% | 00.0% | Unchanged |
| Boxer Capital, LLC | 6,448,359 | $46.1M | 2.92% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 7,236,454 | $51.7M | 1.38% | 00.0% | Unchanged |
| Ensign Peak Advisors, Inc | 0 | $0 | 0.00% | −125,000−100.0% | Sold out |
| Renaissance Technologies LLC | 0 | $0 | 0.00% | −29,300−100.0% | Sold out |
| UBS Group AG | 0 | $0 | 0.00% | −1,740−100.0% | Sold out |
| Amalgamated Financial Corp. | – | – | – | – | Not filed |